ZyVersa Therapeutics Inc. (ZVSA) financials · $1.4M cap
ZyVersa Therapeutics Inc. (ZVSA) $1.4M cap.
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Income | -$25.5M | -$9.1M | -$107.8M |
| Net Income | -$25.0M | -$9.4M | -$98.3M |
| EPS (Diluted) | $-4.18 | $-8.48 | $-108.97 |
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | $347.9K | $20.6M | $22.1M |
| Current Assets | $347.9K | $1.7M | $3.4M |
| Cash & Equivalents | $101.8K | $1.5M | $3.1M |
| Inventory | $0 | $0 | $0 |
| PP&E | $52.0K | $52.0K | $6.9K |
| Total Liabilities | $12.7M | $12.1M | $11.0M |
| Current Liabilities | $12.7M | $11.2M | $10.2M |
| Short-term Debt | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 |
| Shareholders' Equity | -$12.4M | $8.5M | $11.1M |
| Retained Earnings | -$137.6M | -$112.6M | -$103.2M |
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Cash Flow | -$5.1M | -$7.6M | -$8.7M |
| CapEx | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 |
| Financing Cash Flow | $3.7M | $6.0M | $6.0M |
| Dividends Paid | $0 | $0 | $0 |
| Net Change in Cash | -$1.4M | -$1.6M | -$2.8M |
| Free Cash Flow | $0 | $0 | $0 |
FAQ
What is ZVSA P/E and revenue?
ZyVersa Therapeutics Inc. (ZVSA) $1.4M cap.
What is ZVSA revenue?
ZyVersa Therapeutics Inc. last cached revenue is $0 (FY2025).
Is ZVSA profitable?
ZyVersa Therapeutics Inc. last cached net income is -$25.0M.
What are ZVSA total assets?
ZyVersa Therapeutics Inc. last cached total assets are $347.9K.
What is ZVSA free cash flow?
ZyVersa Therapeutics Inc. last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.